We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · January 04, 2021

Prediction Tool of Hearing Loss Associated With Cisplatin Chemotherapy and Radiation in Head and Neck Cancer

JAMA Otolaryngology -- Head & Neck Surgery

 

Additional Info

JAMA Otolaryngology -- Head & Neck Surgery
Validation of Hearing Loss Prediction Tool for Cisplatin Chemotherapy and Radiation in Head and Neck Cancer Treatment
JAMA Otolaryngol Head Neck Surg 2020 Dec 10;[EPub Ahead of Print], BC Deutsch, C Collopy, D Kallogjeri, JF Piccirillo

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading